How to Manage Atrial Fibrillation Secondary to Ibrutinib

Hani Essa; Taha Lodhi; Rebecca Dobson; David Wright; Gregory Y H Lip

doi:10.1016/j.jaccao.2020.11.016

How to Manage Atrial Fibrillation Secondary to Ibrutinib

JACC CardioOncol. 2021 Mar 16;3(1):140-144. doi: 10.1016/j.jaccao.2020.11.016. eCollection 2021 Mar.

Authors

Hani Essa¹, Taha Lodhi², Rebecca Dobson¹, David Wright¹, Gregory Y H Lip^{1

3}

Affiliations

¹ Liverpool Centre for Cardiovascular Science, University of Liverpool, Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.
² Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
³ Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

No abstract available

Keywords: AF, atrial fibrillation; BTK, Bruton’s tyrosine kinase; DOAC, direct oral anticoagulant; ECG, electrocardiogram; LMWH, low molecular weight heparin; OR, odds ratio; arrhythmia; echocardiography; treatment.

Publication types

Review